Protection versus pathology in tuberculosis: Recent insights

Current Opinion in Immunology

Volumn 24, Issue 4, 2012, Pages 431-437

  Cooper, Andrea M ^a   Torrado, Egidio ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD1B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERSTITIAL COLLAGENASE; MICRORNA; MYCOBACTERIUM VACCINE; RV 2260C; RV 3615C; UNCLASSIFIED DRUG; VITAMIN D;

BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL TYPE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNITY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TUBERCULOSIS; VACCINATION;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; TUBERCULOSIS, PULMONARY;

EID: 84865301803     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.04.008     Document Type: Review

References (68)

1. Cooper A.M. Cell mediated immune responses in tuberculosis. Annu Rev Immunol 2009, 27:393-422.
2. Khader S., Rangel-Moreno J., Fountain J., Martino C., Reiley W., Pearl J., Winslow G., Woodland D., Randall T., Cooper A. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol 2009, 183:8004-8014.
3. Day T.A., Koch M., Nouailles G., Jacobsen M., Kosmiadi G.A., Miekley D., Kuhlmann S., Jörg S., Gamradt P., Mollenkopf H.-J., et al. Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis. Eur J Immunol 2010, 40:1663-1673.
4. Robinson R., Khader S., Martino C., Fountain J., Teixeira-Coelho M., Pearl J., Smiley S., Winslow G., Woodland D., Walter M., et al. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rβ1 isoform that enhances DC migration. J Exp Med 2010, 207:591-605.
5. Blomgran R., Desvignes L., Briken V., Ernst J.D. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe 2012, 11:81-90.
6. Blomgran R., Ernst J.D. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol 2011, 186:7110-7119.
7. Divangahi M., Desjardins D., Nunes-Alves C., Remold H.G., Behar S.M. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol 2010, 11:751-758.
8. Shafiani S., Tucker-Heard G., Kariyone A., Takatsu K., Urdahl K.B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010, 207:1409-1420.
9. Koch M., Tucker-Heard G., Perdue N., Killebrew J., Urdahl K., Campbell D. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10:595-602.
10. Vallerskog T., Martens G.W., Kornfeld H. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol 2010, 184:6275-6282.
11. Kasmar A.G., van Rhijn I., Cheng T.-Y., Turner M., Seshadri C., Schiefner A., Kalathur R.C., Annand J.W., de Jong A., Shires J., et al. CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 2011, 208:1741-1747.
12. Montamat-Sicotte D.J., Millington K.A., Willcox C.R., Hingley-Wilson S., Hackforth S., Innes J., Kon O.M., Lammas D.A., Minnikin D.E., Besra G.S., et al. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest 2011, 121:2493-2503.
13. Torrelles J.B., Sieling P.A., Arcos J., Knaup R., Bartling C., Rajaram M.V.S., Stenger S., Modlin R.L., Schlesinger L.S. Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses. J Biol Chem 2011, 286:35438-35446.
14. Meraviglia S., Caccamo N., Salerno A., Sireci G., Dieli F. Partial and ineffective activation of Vγ9Vδ2 T cells by Mycobacterium tuberculosis-infected dendritic cells. J Immunol 2010, 185:1770-1776.
15. Le Bourhis L., Martin E., Péguillet I., Guihot A., Froux N., Coré M., Lévy E., Dusseaux M., Meyssonnier V., Premel V., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010, 11:701-708.
16. Gold M., Cerri S., Smyk-Pearson S., Cansler M., Vogt T., Delepine J., Winata E., Swarbrick G., Chua W., Yu Y., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010, 8:e1000407.
17. Egen J.G., Rothfuchs A.G., Feng C.G., Horwitz M.A., Sher A., Germain R.N. Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 2011, 34:807-819.
18. + effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog 2011, 7:e1002063.
19. Ramachandra L., Qu Y., Wang Y., Lewis C.J., Cobb B.A., Takatsu K., Boom W.H., Dubyak G.R., Harding C.V. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing Major Histocompatibility Complex Class II molecules capable of antigen presentation. Infect Immun 2010, 78:5116-5125.
20. Schreiber H.A., Harding J.S., Hunt O., Altamirano C.J., Hulseberg P.D., Stewart D., Fabry Z., Sandor M. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 2011, 121:3902-3913.
21. Comas I., Chakravartti J., Small P.M., Galagan J., Niemann S., Kremer K., Ernst J.D., Gagneux S. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010, 42:498-503.
22. Reiley W.W., Shafiani S., Wittmer S.T., Tucker-Heard G., Moon J.J., Jenkins M.K., Urdahl K.B., Winslow G.M., Woodland D.L. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 2010, 107:19408-19413.
23. Kohlmeier J.E., Reiley W.W., Perona-Wright G., Freeman M.L., Yager E.J., Connor L.M., Brincks E.L., Cookenham T., Roberts A.D., Burkum C.E., et al. Inflammatory chemokine receptors regulate CD8+ T cell contraction and memory generation following infection. J Exp Med 2011, 208:1621-1634.
24. Curtis M.M., Rowell E., Shafiani S., Negash A., Urdahl K.B., Wilson C.B., Way S.S. Fidelity of pathogen-specific CD4+ T cells to the Th1 lineage is controlled by exogenous cytokines, interferon-γ expression, and pathogen lifestyle. Cell Host Microbe 2010, 8:163-173.
25. Wozniak T.M., Saunders B.M., Ryan A.A., Britton W.J. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 2010, 78:4187-4194.
26. Ma F., Xu S., Liu X., Zhang Q., Xu X., Liu M., Hua M., Li N., Yao H., Cao X. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]. Nat Immunol 2011, 12:861-869.
27. Caccamo N., Guggino G., Joosten S.A., Gelsomino G., Di Carlo P., Titone L., Galati D., Bocchino M., Matarese A., Salerno A., et al. Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40:2211-2220.
28. Sutherland J.S., de Jong B.C., Jeffries D.J., Adetifa I.M., Ota M.O.C. Production of TNF-α, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 2010, 5:e12365.
29. Kim B.-H., Shenoy A.R., Kumar P., Das R., Tiwari S., MacMicking J.D. A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science 2011, 332:717-721.
30. Tiwari S., Choi H.-P., Matsuzawa T., Pypaert M., MacMicking J.D. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P2 and PtdIns(3,4,5)P3 promotes immunity to mycobacteria. Nat Immunol 2009, 10:907-917.
31. Shenoy A.R., Wellington D.A., Kumar P., Kassa H., Booth C.J., Cresswell P., MacMicking J.D. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 2012, 336:481-485.
32. Ponpuak M., Davis A.S., Roberts E.A., Delgado M.A., Dinkins C., Zhao Z., Virgin Iv H.W., Kyei G.B., Johansen T., Vergne I., et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010, 32:329-341.
33. Singh S.B., Ornatowski W., Vergne I., Naylor J., Delgado M., Roberts E., Ponpuak M., Master S., Pilli M., White E., et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat Cell Biol 2010, 12:1154-1165.
34. Fabri M., Stenger S., Shin D.-M., Yuk J.-M., Liu P.T., Realegeno S., Lee H.-M., Krutzik S.R., Schenk M., Sieling P.A., et al. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011, 3:104ra102.
35. Liu P.T., Wheelwright M., Teles R., Komisopoulou E., Edfeldt K., Ferguson B., Mehta M.D., Vazirnia A., Rea T.H., Sarno E.N., et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 2012, 18:267-273.
36. Rajaram M.V.S., Ni B., Morris J.D., Brooks M.N., Carlson T.K., Bakthavachalu B., Schoenberg D.R., Torrelles J.B., Schlesinger L.S. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci USA 2011, 108:17408-17413.
37. Bustamante J., Arias A.A., Vogt G., Picard C., Galicia L.B., Prando C., Grant A.V., Marchal C.C., Hubeau M., Chapgier A., et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 2011, 12:213-221.
38. Sarkar S., Song Y., Sarkar S., Kipen H.M., Laumbach R.J., Zhang J., Ohman Strickland P.A., Gardner C.R., Schwander S. Suppression of the NF-κB pathway by diesel exhaust particles impairs human antimycobacterial immunity. J Immunol 2012, 188:2778-2793.
39. Potian J.A., Rafi W., Bhatt K., McBride A., Gause W.C., Salgame P. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J Exp Med 2011, 208:1863-1874.
40. Cruz A., Fraga A., Fountain J., Rangel-Moreno J., Torrado E., Saraiva M., Pereira D., Randall T., Pedrosa J., Cooper A., et al. Pathological role of Interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 2010, 207:1609-1616.
41. Desvignes L., Ernst J.D. Interferon-γ-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 2009, 31:974-985.
42. Nandi B., Behar S.M. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med 2011, 208:2251-2262.
43. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
44. Dorhoi A., Desel C., Yeremeev V., Pradl L., Brinkmann V., Mollenkopf H.-J., Hanke K., Gross O., Ruland J., Kaufmann S.H.E. The adaptor molecule CARD9 is essential for tuberculosis control. J Exp Med 2010, 207:777-792.
45. Lemos M.P., Rhee K.Y., McKinney J.D. Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression. J Immunol 2011, 187:3776-3784.
46. McNab F.W., Berry M.P.R., Graham C.M., Bloch S.A.A., Oni T., Wilkinson K.A., Wilkinson R.J., Kon O.M., Banchereau J., Chaussabel D., et al. Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur J Immunol 2011, 41:1941-1947.
47. Lazar-Molnar E., Chen B., Sweeney K.A., Wang E.J., Liu W., Lin J., Porcelli S.A., Almo S.C., Nathenson S.G., Jacobs W.R. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci USA 2010, 107:13402-13407.
48. Barber D.L., Mayer-Barber K.D., Feng C.G., Sharpe A.H., Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1 mediated inhibition. J Immunol 2010, 186:1598-1607.
49. O'Kane C.M., Elkington P.T., Jones M.D., Caviedes L., Tovar M., Gilman R.H., Stamp G., Friedland J.S. STAT3, p38 MAPK, and NF-κB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis. Am J Respir Cell Mol Biol 2010, 43:465-474.
50. Green J.A., Elkington P.T., Pennington C.J., Roncaroli F., Dholakia S., Moores R.C., Bullen A., Porter J.C., Agranoff D., Edwards D.R., et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-κB- and activator protein-1-dependent monocyte networks. J Immunol 2010, 184:6492-6503.
51. Elkington P., Shiomi T., Breen R., Nuttall R.K., Ugarte-Gil C.A., Walker N.F., Saraiva L., Pedersen B., Mauri F., Lipman M., et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011, 121:1827-1833.
52. Mayer-Barber K., Barber D., Shenderov K., White S., Wilson M.S., Cheever A., Kugler D., Hieny S., Caspar P., Núñez G., et al. Cutting edge: caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 2010, 184:3326-3330.
53. Mayer-Barber K.D., Andrade B.B., Barber D.L., Hieny S., Feng C.G., Caspar P., Oland S., Gordon S., Sher A. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 2011, 35:1023-1034.
54. Jayaraman P., Sada-Ovalle I., Beladi S., Anderson A.C., Dardalhon V., Hotta C., Kuchroo V.K., Behar S.M. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med 2010, 207:2343-2354.
55. Novikov A., Cardone M., Thompson R., Shenderov K., Kirschman K.D., Mayer-Barber K.D., Myers T.G., Rabin R.L., Trinchieri G., Sher A., et al. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J Immunol 2011, 187:2540-2547.
56. Horne D.J., Randhawa A.K., Chau T.T.H., Bang N.D., Yen N.T.B., Farrar J.J., Dunstan S.J., Hawn T.R. Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J Infect Dis 2012, 205:586-594.
57. Aagaard C., Hoang T., Dietrich J., Cardona P.-J., Izzo A., Dolganov G., Schoolnik G.K., Cassidy J.P., Billeskov R., Andersen P. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011, 17:189-194.
58. Commandeur S., Lin M.Y., van Meijgaarden K.E., Friggen A.H., Franken K.L.M.C., Drijfhout J.W., Korsvold G.E., Oftung F., Geluk A., Ottenhoff T.H.M. Double- and monofunctional CD4+ and CD8+ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals. Eur J Immunol 2011, 41:2925-2936.
59. Tang S.T., van Meijgaarden K.E., Caccamo N., Guggino G., Klein M.R., van Weeren P., Kazi F., Stryhn A., Zaigler A., Sahin U., et al. Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis. J Immunol 2011, 186:1068-1080.
60. Millington K.A., Fortune S.M., Low J., Garces A., Hingley-Wilson S.M., Wickremasinghe M., Kon O.M., Lalvani A. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 2011, 108:5730-5735.
61. Woodworth J.S., Shin D., Volman M., Nunes-Alves C., Fortune S.M., Behar S.M. Mycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccination. J Immunol 2011, 186:1627-1637.
62. Billeskov R., Grandal M.V., Poulsen C., Christensen J.P., Winter N., Vingsbo-Lundberg C., Hoang T.T.K.T., van Deurs B., Song Y.-H., Aagaard C., et al. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4. BCG or infection with Mycobacterium tuberculosis. Eur J Immunol 2010, 40:1342-1354.
63. Lalor M.K., Floyd S., Gorak-Stolinska P., Ben-Smith A., Weir R.E., Smith S.G., Newport M.J., Blitz R., Mvula H., Branson K., et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011, 204:1075-1085.
64. Burl S., Adetifa U.J., Cox M., Touray E., Ota M.O., Marchant A., Whittle H., McShane H., Rowland-Jones S.L., Flanagan K.L. Delaying Bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 2010, 185:2620-2628.
65. Gopal R., Lin Y., Obermajer N., Slight S., Nuthalapati N., Ahmed M., Kalinski P., Khader S.A. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. Eur J Immunol 2012, 42:364-373.
66. Sweeney K.A., Dao D.N., Goldberg M.F., Hsu T., Venkataswamy M.M., Henao-Tamayo M., Ordway D., Sellers R.S., Jain P., Chen B., et al. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med 2011, 17:1261-1268.
67. Nambiar J.K., Pinto R., Aguilo J.I., Takatsu K., Martin C., Britton W.J., Triccas J.A. Protective immunity afforded by attenuated. PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory. Eur J Immunol 2012, 42:385-392.
68. Juárez-Rodríguez M.D., Arteaga-Cortés L.T., Kader R., Curtiss R., Clark-Curtiss J.E. Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system. Infect Immun 2012, 80:798-814.